Lithium Ion

Lithium Ion

SCHEMBL7698371

CN(CC(=O)[O-])C[C@H]1CCc2cc(F)ccc2[C@H]1c1ccc(F)cc1.[Li+]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 2/20 0.53
HTR6 P50406 8/20 0.41
MTNR1A P48039 2/20 0.36
MTNR1B P49286 2/20 0.36
SRD5A1 P18405 3/20 0.34
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
ESR1 P03372 2/20 0.33
PDE10A Q9Y233 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL7703444 0.94 SLC6A9 (0.62) SLC6A9HTR6MTNR1AMTNR1B
Lithium Ion SCHEMBL7706198 0.91 SLC6A9 (0.46) SLC6A9HTR6MTNR1AMTNR1BPDE10A
Lithium Ion SCHEMBL7702956 0.91 SLC6A9 (0.49) SLC6A9HTR6SRD5A1
Lithium Ion SCHEMBL7706037 0.90 SLC6A9 (0.69) SLC6A9HTR6MTNR1AMTNR1BNPC1
Lithium Ion SCHEMBL7704198 0.89 SLC6A9 (0.51) SLC6A9MTNR1AMTNR1B
Lithium Ion SCHEMBL7705019 0.88 SLC6A9 (0.56) SLC6A9HTR6ESR1
Lithium Ion SCHEMBL7698448 0.85 SLC6A9 (0.54) SLC6A9HTR6MTNR1AMTNR1B
Lithium Ion SCHEMBL7703313 0.83 SLC6A9 (0.74) SLC6A9MTNR1ASRD5A1
Lithium Ion SCHEMBL7702844 0.82 SLC6A9 (0.63) SLC6A9HTR6MTNR1AMTNR1B
Lithium Ion SCHEMBL7702768 0.81 SLC6A9 (0.60) SLC6A9MTNR1AMTNR1BSRD5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100769-B1 AMINOMETHYLCARBOXYLIC ACID DERIVATIVES AKZO NOBEL NV (NL) 2002-12-04 EP disclosed
US-6410592-B1 THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS AKZO NOBEL N.V. (NL) 2002-06-25 US disclosed